The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001130987.2(DYSF):c.959dup (p.Asp320fs)

CA533254006

2674961 (ClinVar)

Gene: DYSF (HGNC:8291)
Condition: autosomal recessive limb-girdle muscular dystrophy (MONDO:0015152)
Inheritance Mode: Autosomal recessive inheritance
UUID: b74affdc-5f90-46bf-b094-50f735774930
Approved on: 2025-07-29
Published on: 2025-08-14

HGVS expressions

NM_001130987.2(DYSF):c.959dup (p.Asp320fs)
NM_001130987.2:c.959dup
NC_000002.12:g.71516996dup
CM000664.2:g.71516996dup
NC_000002.11:g.71744126dup
CM000664.1:g.71744126dup
NC_000002.10:g.71597634dup
NG_008694.1:g.68374dup
ENST00000258104.8:c.863dup
ENST00000410020.8:c.959dup
ENST00000258104.7:c.863dup
ENST00000394120.6:c.866dup
ENST00000409366.5:c.866dup
ENST00000409582.7:c.956dup
ENST00000409651.5:c.959dup
ENST00000409744.5:c.866dup
ENST00000409762.5:c.956dup
ENST00000410020.7:c.959dup
ENST00000410041.1:c.959dup
ENST00000413539.6:c.956dup
ENST00000429174.6:c.863dup
NM_001130455.1:c.866dup
NM_001130976.1:c.863dup
NM_001130977.1:c.863dup
NM_001130978.1:c.863dup
NM_001130979.1:c.956dup
NM_001130980.1:c.956dup
NM_001130981.1:c.956dup
NM_001130982.1:c.959dup
NM_001130983.1:c.866dup
NM_001130984.1:c.866dup
NM_001130985.1:c.959dup
NM_001130986.1:c.866dup
NM_001130987.1:c.959dup
NM_003494.3:c.863dup
NM_001130455.2:c.866dup
NM_001130976.2:c.863dup
NM_001130977.2:c.863dup
NM_001130978.2:c.863dup
NM_001130979.2:c.956dup
NM_001130980.2:c.956dup
NM_001130981.2:c.956dup
NM_001130982.2:c.959dup
NM_001130983.2:c.866dup
NM_001130984.2:c.866dup
NM_001130985.2:c.959dup
NM_001130986.2:c.866dup
NM_003494.4:c.863dup
More

Pathogenic

Met criteria codes 3
PVS1 PM2_Supporting PM3_Supporting
Not Met criteria codes 1
PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DYSF Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_003494.4: c.863dup p.(Asp288GlufsTer40) variant in DYSF, which is also known as NM_001130987.2: c.959dup p.(Asp320GlufsTer40), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 11/55, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been identified in at least two individuals with dysferlinopathy (PMID: 36983702, 33715265, 14673575; LOVD DYSF_000186), including in unknown phase with a pathogenic variant (NM_003494.4: c.3031+2T>C, 0.5 pts, PMID: 36983702; PM3_Supporting). The filtering allele frequency of this variant in gnomAD v4.1.0 exomes is 0.000008232 (the upper threshold of the 95% CI of 4/1111996 European (non-Finnish) chromosomes), which is lower than the ClinGen LGMD VCEP threshold (<0.0001) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb-girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 07/29/2025): PVS1, PM3_Supporting, PM2_Supporting.
Met criteria codes
PVS1
The NM_003494.4: c.863dup p.(Asp288GlufsTer40) variant in DYSF, which is also known as NM_001130987.2: c.959dup p.(Asp320GlufsTer40), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 11/55, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1).
PM2_Supporting
The filtering allele frequency of this variant in gnomADv4.1.0 exomes is 0.000008232 (the upper threshold of the 95% CI of 4/1111996 European (non-Finnish) chromosomes), which is lower than the ClinGen LGMD VCEP threshold (<0.0001) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting).
PM3_Supporting
This variant has been identified in at least two individuals with dysferlinopathy (PMID: 36983702, 33715265, 14673575; LOVD DYSF_000186), including in unknown phase with a pathogenic variant (NM_003494.4: c.3031+2T>C, 0.5 pts, PMID: 36983702; PM3_Supporting). c.3031+2T>C is independently classified as P and is not found in gnomAD v2 so cannot check co-occurrence
Not Met criteria codes
PP4
Cannot conclusively determine that one patient met genetic, clinical, and protein expression criteria. Cannot definitively confirm that Fernández-Eulate and Rufibach cases are the same individual, and cannot exclude possibility that in Fernández-Eulate case, protein expression was from family member. Walter case had only 1 presumed diagnostic variant identified.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.